RDIF, Pharma Firm Hetero Agree to Produce Over 100 Million Doses of Sputnik Covid Vaccine in India in Top Business News- News18.com published on November 27, 2020 leave a reply The parties intend to start the production of Sputnik V in the beginning of 2021, it added.</p> from Top Business News- News18.com https://ift.tt/37bFJAe Tweet Share Share Share Share Previous Post Gold On Track For Weekly Fall As Investors Overlook Vaccine Doubts Next Post NSE Declares Anugrah Stock and Broking as Defaulter, Expels Membership post written by: Rohit Related PostsWeekly Stocks Update: Top Gainers and Losers for the Week Ended November 15For the week ended on November 15, the S&P BSE Sensex inched up by just 33 points, or 0.08%, to settle at 40,356.69, while the Nifty slipped marginally by 1… Continue ReadingAIIB Expects Investment Worth $100 Million a Year in India's Renewable ProjectsAIIB expects to tap as much as USD 100 million green and renewable projects in India from next month, bank's Director General (Investment Operations) Pang Yee E… Continue ReadingFPIs Infuse Rs 19,203 Crore into Indian Capital Markets in November So FarAccording to the latest depositories data, overseas investors infused a net amount of Rs 14,435.6 crore into equities and Rs 4,767.18 crore into the debt segmen… Continue ReadingAnil Ambani Resigns as Director of Reliance CommunicationsAccording to the filing, Ambani along with Chhaya Virani, Ryna Karani, Manjari Kacker, Suresh Rangachar have resigned as directors of RCom. from Top Business N… Continue ReadingSix of Top-10 Firms Add Rs 2.4 Lakh Crore in M-cap; TCS Leads ChargeThe other winners included Reliance Industries Ltd (RIL), HDFC Bank, Kotak Mahindra Bank, ICICI Bank and SBI, while HUL, Infosys, ITC and HDFC suffered losses i… Continue Reading
0 comments: